Date	Period	Revenue/Estimate	Earnings Call
Dec 12, 2024	2025/Q3	1.888B / --	--
Jun 11, 2024	2025/Q1	1.921B / --	--
Dec 8, 2023	2024/Q3	1.933B / --	--
Jun 9, 2023	2024/Q1	1.846B / 1.940B	--
Mar 10, 2023	2023/Q4	1.993B / 1.969B	--

DatePeriodRevenue/EstimateEarnings Call

Dec 12, 20242025/Q31.888B / ----

Jun 11, 20242025/Q11.921B / ----

Dec 8, 20232024/Q31.933B / ----

Jun 9, 20232024/Q11.846B / 1.940B--

Mar 10, 20232023/Q41.993B / 1.969B--

Unlock Free Earnings Estimates

Open Account

OSG Earnings Reports

OSG: Summary of Financial Results for the 3rd Quarter Ending January 2025 [Japanese GAAP] (Consolidated)

Dec 12, 2024 01:30 ET

OSG: Confirmation letter

Sep 12, 2024 23:33 ET

OSG: Semi-annual report - 55th period (2024/02/01 - 2025/01/31)

Sep 12, 2024 23:31 ET

OSG: Notice regarding differences between earnings forecasts and actual values for the second quarter (interim period) of the fiscal year ending January 2025

Sep 10, 2024 02:30 ET

Symbol Price % Chg

D. Western Therapeutics Institute

4576

201 +23.31%

See the daily top gainer.